National Center for Complementary & Alternative Medicine; Notice of Meeting, 19379-19380 [2011-8314]
Download as PDF
Federal Register / Vol. 76, No. 67 / Thursday, April 7, 2011 / Notices
Place: NIEHS/National Institutes of Health,
Building 4401, East Campus, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709, (Virtual Meeting).
Contact Person: RoseAnne M. McGee,
Associate Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research and Training, Nat.
Institute of Environmental Health Sciences,
P.O. Box 12233, MD EC–30, Research
Triangle Park, NC 27709, (919) 541–0752,
mcgee1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: March 31, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 31, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–8315 Filed 4–6–11; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2011–8316 Filed 4–6–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Center
for Scientific Review Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Center for Scientific
Review Advisory Council.
Date: May 2, 2011.
Time: 8:15 a.m. to 4 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room E1/
E2, Bethesda, MD 20892.
Contact Person: Cheryl A. Kitt, Ph.D.,
Executive Secretary, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 3030, MSC 7776,
Bethesda, MD 20892, 301–435–1112,
kittc@csr.nih.gov.
VerDate Mar<15>2010
19:53 Apr 06, 2011
Jkt 223001
National Center for Complementary &
Alternative Medicine; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract Proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable materials, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
19379
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: June 3, 2011.
Closed: June 3, 2011, 8:30 a.m. to 10:30
a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Open: June 3, 2011, 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director
of the National Center for Complementary
and Alternative Medicine, presentation of a
new research initiative, and other business of
the Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Martin H. Goldrosen,
Ph.D., Executive Secretary, Director, Division
of Extramural Activities, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 594–2014.
The public comments session is scheduled
from 3:30 to 4 p.m. on June 3, 2011, but
could change depending on the actual time
spent on each agenda item. Each speaker will
be permitted 5 minutes for their presentation.
Interested individuals and representatives of
organizations are requested to notify Dr.
Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland, 20892, 301–594–2014,
Fax: 301–480–9970. Letters of intent to
present comments, along with a brief
description of the organization represented,
should be received no later than 5 p.m. on
May 26, 2011. Only one representative of an
organization may present oral comments.
Any person attending the meeting who does
not request an opportunity to speak in
advance of the meeting may be considered
for oral presentation, if time permits, and at
the discretion of the Chairperson. In
addition, written comments may be
submitted to Dr. Martin H. Goldrosen at the
address listed above up to ten calendar days
(June 13, 2011) following the meeting.
Copies of the meeting agenda and the
roster of members will be furnished upon
request by contacting Dr. Martin H.
Goldrosen, Executive Secretary, NACCAM,
National Center for Complementary and
Alternative Medicine, National Institutes of
Health, 6707 Democracy Boulevard, Suite
401, Bethesda, Maryland 20892, 301–594–
2014, Fax 301–480–9970, or via e-mail at
naccames@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
nccam.nih.gov/about/naccam, where an
E:\FR\FM\07APN1.SGM
07APN1
19380
Federal Register / Vol. 76, No. 67 / Thursday, April 7, 2011 / Notices
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.701, ARRA Related
Biomedical Research and Research Support
Awards; 93.213, Research and Training in
Complementary and Alternative Medicine,
National Institutes of Health, HHS)
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Dated: April 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–8314 Filed 4–6–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
Proposed Project: 2012 National Survey
on Drug Use and Health—(OMB No.
0930–0110)—Revision
The National Survey on Drug Use and
Health (NSDUH) is a survey of the
civilian, non-institutionalized
population of the United States 12 years
old and older. The data are used to
determine the prevalence of use of
tobacco products, alcohol, illicit
substances, and illicit use of
prescription drugs. The results are used
by SAMHSA, ONDCP, Federal
government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
The 2012 and 2013 NSDUHs will
continue conducting a follow-up
clinical interview with a subsample of
approximately 1,500 respondents. The
design of this Mental Health
Surveillance Study (MHSS) is based on
the recommendations from a panel of
expert consultants convened by the
Center for Mental Health Services
(CMHS), SAMHSA, to discuss mental
health surveillance data collection
strategies. The goal is to create a
statistically sound measure that may be
used to estimate the prevalence of
Serious Mental Illness (SMI) among
adults (age 18+).
For the 2012 and 2013 NSDUHs, no
questionnaire changes are proposed.
As with all NSDUH/NHSDA surveys
conducted since 1999, the sample size
of the survey for 2012 and 2013 will be
sufficient to permit prevalence estimates
for each of the fifty states and the
District of Columbia. The total annual
burden estimate is shown below:
ESTIMATED ANNUAL BURDEN FOR 2012/2013 NSDUH
Responses
per
respondent
No. of
respondents
Instrument
Hours per response
Total
burden hours
Hourly wage
rate
Annualized
hourly costs
Household Screening ...............................
Interview ...................................................
Clinical Follow-up Certification .................
Clinical Follow-up Interview .....................
Screening Verification ..............................
Interview Verification ................................
191,100
67,500
90
1,500
5,400
10,125
1
1
1
1
1
1
0.083
1.000
1.000
1.000
0.067
0.067
15,861
67,500
90
1,500
362
678
$14.71
14.71
14.71
14.71
14.71
14.71
$233,315
992,925
1,324
22,065
5,325
9,973
Total ..................................................
191,190
........................
........................
85,991
........................
1,264,927
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 8–1099, One Choke Cherry Road,
Rockville, MD 20857 And e-mail a copy
to summer.king@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
mstockstill on DSKH9S0YB1PROD with NOTICES
Dated: March 30, 2011.
Elaine Parry,
Director, Office of Management, Technology
and Operations.
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2011–0187]
VerDate Mar<15>2010
19:53 Apr 06, 2011
ACTION:
The Coast Guard announces
the date for the entry into effect of
discharge requirements from ships in
the Wider Caribbean Region (WCR)
special area (SA) as specified in the
International Convention for the
Prevention of Pollution from Ships
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
The docket for this notice is
available for inspection or copying at
the Docket Management Facility (M–30),
U.S. Department of Transportation,
West Building Ground Floor, Room
W12–140, 1200 New Jersey Avenue SE.,
Washington, DC 20590, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays. You may also
find this docket on the Internet by going
ADDRESSES:
Coast Guard, DHS.
Notice.
AGENCY:
SUMMARY:
Jkt 223001
IMO Resolution MEPC.191(60)
established the date of entry for
discharge requirements in the WCR SA
as May 1, 2011.
DATES:
Notice of Entry Into Effect of MARPOL
Annex V Wider Caribbean Region
Special Area
[FR Doc. 2011–8293 Filed 4–6–11; 8:45 am]
BILLING CODE 4162–20–P
(MARPOL) Annex V, Regulation 5 and
Coast Guard regulations. MARPOL
Annex V and the U.S. regulations apply
to vessel and reception facility activities
in the WCR region.
E:\FR\FM\07APN1.SGM
07APN1
Agencies
[Federal Register Volume 76, Number 67 (Thursday, April 7, 2011)]
[Notices]
[Pages 19379-19380]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8314]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the National Advisory
Council for Complementary and Alternative Medicine (NACCAM) meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract Proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable materials, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: June 3, 2011.
Closed: June 3, 2011, 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Open: June 3, 2011, 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director of the National Center
for Complementary and Alternative Medicine, presentation of a new
research initiative, and other business of the Council.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Martin H. Goldrosen, Ph.D., Executive Secretary,
Director, Division of Extramural Activities, National Center for
Complementary and Alternative Medicine, National Institutes of
Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301)
594-2014.
The public comments session is scheduled from 3:30 to 4 p.m. on
June 3, 2011, but could change depending on the actual time spent on
each agenda item. Each speaker will be permitted 5 minutes for their
presentation. Interested individuals and representatives of
organizations are requested to notify Dr. Martin H. Goldrosen,
National Center for Complementary and Alternative Medicine, NIH,
6707 Democracy Boulevard, Suite 401, Bethesda, Maryland, 20892, 301-
594-2014, Fax: 301-480-9970. Letters of intent to present comments,
along with a brief description of the organization represented,
should be received no later than 5 p.m. on May 26, 2011. Only one
representative of an organization may present oral comments. Any
person attending the meeting who does not request an opportunity to
speak in advance of the meeting may be considered for oral
presentation, if time permits, and at the discretion of the
Chairperson. In addition, written comments may be submitted to Dr.
Martin H. Goldrosen at the address listed above up to ten calendar
days (June 13, 2011) following the meeting.
Copies of the meeting agenda and the roster of members will be
furnished upon request by contacting Dr. Martin H. Goldrosen,
Executive Secretary, NACCAM, National Center for Complementary and
Alternative Medicine, National Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax
301-480-9970, or via e-mail at naccames@mail.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: nccam.nih.gov/about/naccam, where an
[[Page 19380]]
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.701, ARRA
Related Biomedical Research and Research Support Awards; 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: April 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-8314 Filed 4-6-11; 8:45 am]
BILLING CODE 4140-01-P